Knee infections are treated with antibiotics chosen to match the specific bacteria causing the infection, but treatment almost always starts with intravenous (IV) antibiotics in a hospital before culture results come back. The most common combination given initially is vancomycin paired with ceftriaxone, which together cover the broadest range of likely bacteria. From there, the antibiotic plan gets narrowed once doctors identify the exact organism from fluid drawn out of the joint.
Why the Bacteria Matters
The antibiotic your doctor picks depends entirely on which bacterium is causing the infection. Staphylococcus aureus is the single most common cause of septic arthritis in the knee, followed by Streptococcus species. In older adults, gram-negative bacteria like E. coli account for roughly 23% to 30% of cases. Less commonly, infections can come from fungi, viruses, or tuberculosis-related bacteria, each requiring completely different treatment.
To identify the culprit, doctors draw fluid from the knee joint using a needle (called arthrocentesis). If the fluid contains more than 50,000 white blood cells per cubic millimeter, septic arthritis is strongly suspected. A gram stain and culture of that fluid then guide the switch from broad-spectrum antibiotics to targeted ones.
First-Line IV Antibiotics
Because waiting days for culture results while an infection destroys cartilage is not an option, doctors start empiric therapy right away. The standard initial combination is vancomycin plus ceftriaxone. Vancomycin covers MRSA and other resistant staph bacteria. Ceftriaxone, a long-acting cephalosporin, is effective against nearly all the gram-negative and gut-related organisms that cause septic arthritis, as well as gonorrhea-related infections.
If Pseudomonas is a concern (common in IV drug users or people with weakened immune systems), cefepime may be used instead of ceftriaxone because it has broader gram-negative coverage, including Pseudomonas. For patients with severe penicillin or cephalosporin allergies, ciprofloxacin can substitute for ceftriaxone to cover gram-negative bacteria, and aztreonam is another alternative that handles gram-negative organisms without triggering beta-lactam allergies.
MRSA-Specific Treatment
When MRSA is confirmed or strongly suspected, vancomycin is the primary IV option. Doctors monitor blood levels of the drug closely, aiming for trough concentrations between 15 and 20 micrograms per milliliter for serious infections. Daptomycin given once daily through an IV is the main alternative when vancomycin cannot be used or isn’t working.
For MRSA joint infections specifically, the Infectious Diseases Society of America recommends a 3 to 4 week course of antibiotics. Some experts add rifampin (an antibiotic with strong biofilm-penetrating properties) to whichever primary antibiotic is chosen, though rifampin is only added after any bloodstream infection has cleared. If the infection also involves the bone near the joint, the minimum treatment course extends to 8 weeks.
Switching to Oral Antibiotics
After an initial period of IV therapy, many patients transition to oral antibiotics to complete their course. Recent evidence shows that oral therapy can be as effective as IV therapy, provided the bacteria are susceptible to the chosen drug and the antibiotic reaches adequate concentrations in bone and joint tissue. Not all oral antibiotics penetrate joints well enough to work, so the options are more limited than for a typical skin infection.
The oral antibiotics with the best track record for bone and joint infections include:
- Rifampin: 70% to 90% oral bioavailability with potent activity against staph bacteria, almost always used in combination with another antibiotic rather than alone.
- Clindamycin: Excellent bone penetration and oral bioavailability. Often used alone or in combination for long-term oral treatment of staph joint infections.
- Fluoroquinolones (ciprofloxacin, levofloxacin): Achieve bone concentrations higher than what’s needed to kill most causative organisms. Particularly useful for gram-negative infections.
- Doxycycline or minocycline: Good tissue penetration and better activity against staph than older tetracyclines.
- Trimethoprim-sulfamethoxazole (TMP-SMX): Sometimes combined with rifampin for outpatient MRSA treatment.
- Linezolid: An option for resistant infections, though it requires monitoring for side effects during longer courses.
Prosthetic Knee Infections
Infections around knee replacements are a different challenge. Bacteria form biofilms on the surface of implants, essentially creating a protective shield that standard antibiotics struggle to penetrate. Treatment of prosthetic joint infections requires antibiotics specifically chosen for their biofilm activity.
Rifampin is central to treating staph biofilm infections on implants because it penetrates biofilms far better than most antibiotics. Newer agents like dalbavancin, a long-acting IV antibiotic, have shown promising activity against gram-positive biofilms including MRSA and resistant staph epidermidis. Prosthetic infections almost always require longer antibiotic courses than native joint infections, and many cases also need surgery to wash out the joint or, in severe situations, remove and eventually replace the implant.
How Long Treatment Lasts
For a native knee (no implant), the typical antibiotic course for septic arthritis is 3 to 4 weeks. The first portion is given intravenously in the hospital, and the remainder may be completed orally at home depending on how well you respond and which bacteria are involved. If the infection has spread to the bone, expect a minimum of 8 weeks of treatment.
Beyond antibiotics, most patients also need one or more joint drainage procedures to remove infected fluid. This can be done with a needle at the bedside or through arthroscopic surgery. The combination of drainage and antibiotics together is what resolves the infection. Antibiotics alone, without removing the infected fluid, are rarely sufficient. Recovery timelines vary, but physical therapy to restore knee range of motion typically begins once the infection is under control and inflammation has settled.